RET and non-small cell lung carcinoma: Compared with other alternative oncogenic aberrations recognized in NSCLC, RET fusion-positive lung carcinomas had more poorly differentiated tumors, suggesting that this kind of genetic aberration defines a unique molecular and clinicopathological subtype [38].